Skip to main content

Table 2 Hypertension outcomes among the 454 Tanzanian adult study participants

From: Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study

Variable HIV-negative HIV-infected, P-value HIV-infected, P-value
Proportion (%) control ART-naïve versus on ART versus
Median [IQR] (number = 153) (number = 151) control (number = 150) control
Hypertension a 25 (16.3%) 8 (5.3%) 0.003 b 43 (28.7%) 0.01
Systolic blood pressure 120 [110 to 130] 115 [110 to 120] 0.007 120 [110 to 137.5] 0.16
Diastolic blood pressure 75 [70 to 80] 75 [70 to 80] 0.04 80 [70 to 90] 0.11
Heart rate 73 [70 to 77] 74 [70 to 79] 0.35 74 [69.5 to 85] 0.18
Hypertension grade    P-value for trend   P-value for trend
Normal 66 (43.1%) 69 (45.7%)   49 (32.7%)  
Prehypertension 62 (40.5%) 74 (49.0%) 0.16 58 (38.7%) 0.01
Grade 1 hypertension 20 (13.1%) 7 (4.6%)   33 (22.0%)  
Grade 2 hypertension 5 (3.3%) 1 (0.7%)   10 (6.7%)  
  1. aPrimary outcome: hypertension defined as average SBP >140 and/or DBP >90 and/or currently taking antihypertensive medications. bThroughout the tables, bolding has been used to indicate those p-values and odds ratios which were statistically significant. ART, antiretroviral therapy; IQR, interquartile range.